Helping back pain sufferers to st...(ondition that comes and goes. Some emplo...)
Navigation Links
Helping back pain sufferers to stay in work
Date:2/22/2008
ondition that comes and goes. Some employers really want to help but dont know who to ask for advice, while others think their staff are malingering, and the company cant afford to keep them on. Closer links with local employers will increase their understanding of managing back pain at work.
After interviewing 16 patients and asking local GPs about problems employees face in working with back pain, and what would make it easier, Mrs Coole will run a feasibility trial of 30 people with back pain. The aim will be to find out whether the Nottingham Back Team course, or a more work-focused rehab programme, is more effective.
'/>"/>
| Contact: Carol Coole Carolyn.coole@nottingham.ac.uk University of Nottingham Source:Eurekalert |
Related biology news :
1. Conference to examine role technology can play in helping US manage healthcare costs
2. A helping hand from the grandparents
3. New Swedish research hope for millions of sufferers
4. New hope for hepatitis C sufferers
Post Your Comments:
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5New discoveries could improve climate projections 2Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 1Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 2Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 3JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 1JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 2JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 3Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 1Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 2Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 3
Other Biology News:Researchers develop new ultrasensitive assay to detect most poisonous substance known 2Early treatment of stomach infection may prevent cancer 2Early treatment of stomach infection may prevent cancer 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 2US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 4
Breaking Biology Technology:China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5
[0] China Biologic Products to Ring NASDAQ Opening Bell[0] Lotus Pharmaceuticals, Inc. Appoints OTC Division Head[0] Martek Signs Sole-Source Supply Agreement with Fonterra[0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
Other Biology Technology:Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 2Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 3ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 2ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 3
Biology Products:
Duck Anti-Cobra venom - Fab Fragment Polyclonal Antibody, Unconjugated from AbcamAnti-Human C5a / C5a des-Arg (neo-epitode) Monoclonal Antibody, Unconjugated, Clone 2952 from Cell SciencesFetuin from Equitech-BioAnti-Laminin alpha 2 (Merosin M chain) Monoclonal Antibody, Unconjugated, Clone 5H2 from CHEMICON
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |